This revolutionary drug could fix spinal cord injuries
Lead author of study says that the drug is very important as there is currently no cure for chronic spinal cord injury
Scientists have developed an injection that is being called "revolutionary".
According to a new study, the drug TTK21 has the potential to repair spinal cord injuries. It was tested on paralysed mice who ended up regrowing nerves within three months of being injected with it.
Lead author Dr Simone Di Giovanni of Imperial College London said in a media release that the drug was very important as there is currently no cure for chronic spinal cord injury.
In such an injury, neuronal regrowth and repair fail. TTK21, however, seems to increase neuronal transmission in the synapses and promote neuronal growth.
The damage to the spinal cord is not limited to the back but interferes with the stream of electrical signals traveling from the brain to the rest of the body. This can cause paralysis in the limbs.
The study published in the journal PLOS Biology said the new drug can regenerate axons which are long spindly parts of a nerve cell.
At the moment, only physical rehabilitation helps injured people regain some mobility. Apart from that, there are no drugs to cure a chronic spinal cord injury.
The mice were given the drug for 12 weeks following a severe injury. Researchers saw that TTK21 helped the regrowth of motor and sensory neurons.
It is an epigenetic activator that targets damaged DNA.
According to Dr Giovanni, the increase in sensory axon growth could be due to an increase in gene expression related to regeneration.
He added that experts were exploring new strategies to use the drug and combine it with other biomaterials to "improve disability in SCI patients".
-
First US measles deaths of 2026 reported in Pennsylvania
-
NHS England to roll out free home testing kits for cervical cancer
-
New study reveals irregular sleep patterns accelerate biological aging
-
80% of young adults already have heart risk factors: Study finds
-
Australia confirms first H5N1 bird flu case in mammals after seal dies due to infection
-
Study reveals why female immunity differs from men's–The science of the biological divide
-
12% of physicians report non-medical GLP-1 use in sport
-
Doctors warn breast cancer is surging among Asian American women
-
France joins Canada and European nations in legalising assisted dying
-
Moderna, Merck ‘personalized’ cancer vaccine succeeds in late-stage melanoma trial
-
UK Salmonella outbreak: Imported eggs linked to one death, hundreds sickened
-
Toronto Public Health investigates Legionnaires disease outbreak after six cases